Difference between revisions of "Team:Calgary"

Line 24: Line 24:
 
         <div class="text-area">
 
         <div class="text-area">
 
           <div class="page-banner">
 
           <div class="page-banner">
             <h2 style="font-family:sans-serif;"class="page-subtitle"><mark>Oviita</mark></h2>
+
             <h2 style="font-family:Barlow, sans-serif;"class="page-subtitle"><mark>Oviita</mark></h2>
 
             <h1 style="font-family:Barlow;"class="page-title"><mark>Vitamin A Deficiency Solution</mark></h1>
 
             <h1 style="font-family:Barlow;"class="page-title"><mark>Vitamin A Deficiency Solution</mark></h1>
 
           </div>
 
           </div>

Revision as of 19:59, 27 June 2020

-->

Oviita

Vitamin A Deficiency Solution

As the leading cause of blindness and childhood mortality, Vitamin A Deficiency (VAD) is a significant global health concern, affecting those with undiversified and insubstantial diets. Current mitigative efforts have had limited success due to consumer reluctance and their failure to consider lipid deficiency, an equally concerning condition that impedes Vitamin A uptake.

In order to provide a sustainable, community-based solution, we plan to genetically modify Rhodotorula glutinis, an oleaginous yeast that naturally produces beta-carotene and lipids, to be more robust and resource-efficient. By modifying the yeast to produce cellulase, it can then use common agricultural waste products as an energy source for synthesizing its oil. It can then be eaten as a vitamin A supplement. The yeast strain, while naturally safe and non-pathogenic, will also be genetically modified to include a kill switch for bio-containment, and optimized for oil production.